SCHEMBL6204787

SCHEMBL6204787

OC(F)c1cccc(Br)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.44
TDO2 P48775 1/20 0.44
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 1/20 0.39
PGK1 P00558 2/20 0.39
PGK2 P07205 2/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2D6 P10635 3/20 0.39
SLC6A2 P23975 3/20 0.39
SLC6A4 P31645 3/20 0.39
SLC6A3 Q01959 3/20 0.39
KCNH2 Q12809 1/20 0.39
C1S P09871 1/20 0.38
PARP1 P09874 1/20 0.38
SLC18A3 Q16572 1/20 0.37
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31191381 0.83 CYP3A4 (0.43) IDO1TDO2ALDH1A1MAPK1PGK1
SCHEMBL31191116 0.83 CYP3A4 (0.43) IDO1TDO2ALDH1A1MAPK1PGK1
SCHEMBL31191121 0.83 CYP3A4 (0.43) IDO1TDO2ALDH1A1MAPK1PGK1
SCHEMBL5872085 0.81 IDO1 (0.47) IDO1TDO2ALDH1A1MAPK1CYP3A4
SCHEMBL31476387 0.81 IDO1 (0.47) IDO1TDO2ALDH1A1MAPK1CYP3A4
SCHEMBL5773097 0.81 CYP3A4 (0.47) IDO1TDO2ALDH1A1MAPK1CYP3A4
SCHEMBL29427058 0.81 IDO1 (0.47) IDO1TDO2ALDH1A1MAPK1C1S
SCHEMBL5911692 0.81 CYP3A4 (0.47) IDO1TDO2ALDH1A1MAPK1CYP3A4
SCHEMBL241692 0.81 IDO1 (0.47) IDO1TDO2ALDH1A1MAPK1CYP3A4
SCHEMBL248466 0.81 IDO1 (0.47) IDO1TDO2ALDH1A1MAPK1C1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed